Cabıoğlu N - Search Results

1

Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy.

Cabıoğlu N, Karanlık H, Yılmaz R, Emiroğlu S, Tükenmez M, Bademler S, Şimşek DH, Kantarcı TR, Yirgin İK, Bayram A, Dursun M. Cabıoğlu N, et al. World J Surg Oncol. 2024 Jul 6;22(1):178. doi: 10.1186/s12957-024-03413-6. World J Surg Oncol. 2024. PMID: 38971793 Free PMC article.

2

Manipulating the chemokine-chemokine receptor network to treat cancer.

Ruffini PA, Morandi P, Cabioglu N, Altundag K, Cristofanilli M. Ruffini PA, et al. Among authors: cabioglu n. Cancer. 2007 Jun 15;109(12):2392-404. doi: 10.1002/cncr.22706. Cancer. 2007. PMID: 17503430 Free article. Review.

3

CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation.

Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, Tuzlali S, Pumiglia K, Gallick GE, Price JE. Cabioglu N, et al. Cancer Res. 2005 Aug 1;65(15):6493-7. doi: 10.1158/0008-5472.CAN-04-1303. Cancer Res. 2005. PMID: 16061624

4

Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report.

Emiroglu M, Akcan A, Velidedeoglu M, Girgin S, Aytac O, Canturk NZ, Yilmaz KB, Koksal H, Cabioglu N, Cetin K, Gulluoglu B. Emiroglu M, et al. Among authors: cabioglu n. Breast Care (Basel). 2024 Oct;19(5):243-251. doi: 10.1159/000541482. Epub 2024 Sep 18. Breast Care (Basel). 2024. PMID: 39439860

5

Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome.

Ozmen V, Cabioglu N, Dolay K, Bilir A, Kecer M, Aydiner A, Muslumanoglu M, Igci A, Bozfakioglu Y, Dagoglu T. Ozmen V, et al. Among authors: cabioglu n. Breast Cancer Res Treat. 2001 Jul;68(2):147-57. doi: 10.1023/a:1011956502082. Breast Cancer Res Treat. 2001. PMID: 11688518

6

Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer.

Ozmen V, Muslumanoglu M, Cabioglu N, Tuzlali S, Ilhan R, Igci A, Kecer M, Bozfakioglu Y, Dagoglu T. Ozmen V, et al. Among authors: cabioglu n. Breast Cancer Res Treat. 2002 Dec;76(3):237-44. doi: 10.1023/a:1020890921238. Breast Cancer Res Treat. 2002. PMID: 12462384

7

Inflammatory breast cancer: results of antracycline-based neoadjuvant chemotherapy.

Ozmen V, Cabioglu N, Igci A, Dagoglu T, Aydiner A, Kecer M, Bozfakioglu Y, Dinçer M, Bilir A, Topuz E. Ozmen V, et al. Among authors: cabioglu n. Breast J. 2003 Mar-Apr;9(2):79-85. doi: 10.1046/j.1524-4741.2003.09204.x. Breast J. 2003. PMID: 12603379

8

Thymidine labeling index: prognostic role in breast cancer.

Bilir A, Ozmen V, Kecer M, Eralp Y, Cabioglu N, Ahishali B, Camlica H, Aydiner A. Bilir A, et al. Among authors: cabioglu n. Am J Clin Oncol. 2004 Aug;27(4):400-6. doi: 10.1097/01.coc.0000128867.95368.9e. Am J Clin Oncol. 2004. PMID: 15289735

9

Feasibility of surgical management in patients with granulomatous mastitis.

Asoglu O, Ozmen V, Karanlik H, Tunaci M, Cabioglu N, Igci A, Selcuk UE, Kecer M. Asoglu O, et al. Among authors: cabioglu n. Breast J. 2005 Mar-Apr;11(2):108-14. doi: 10.1111/j.1075-122X.2005.21576.x. Breast J. 2005. PMID: 15730456

10

Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.

Ozmen V, Karanlik H, Cabioglu N, Igci A, Kecer M, Asoglu O, Tuzlali S, Mudun A. Ozmen V, et al. Among authors: cabioglu n. Breast Cancer Res Treat. 2006 Jan;95(1):1-6. doi: 10.1007/s10549-005-9007-9. Breast Cancer Res Treat. 2006. PMID: 16322900 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters